Adele Visit 1: A 61-year-old postmenopausal female with sexual health issues

Title:

Adele Visit 1: A 61-year-old postmenopausal female with sexual health issues

Topic: Sexuality
Relevant Terms: Gynecology, Hormone Therapy, Menopause
Primary Audience: Gynecologists, Internists, Nurse Practitioners, Physician Assistants, Primary Care Physicians, Urologists
Launch Date: 04-May-12
Credits: 0.5 AMA PRA Category 1 Credit
1 CA-BRN contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Identifying and Treating Vulvovaginal Atrophy in Postmenopausal Women

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Communicate about sexual health issues regularly with female patients to improve screening for vaginal symptoms
  2. Utilize evidence-based tools and resources to identify vulvovaginal atrophy in peri- and postmenopausal patients
  3. Develop an individualized treatment plan for each patient with vulvovaginal atrophy

    Faculty

    Sharon Parish, MD
    Associate Professor of Medicine
    Albert Einstein School of Medicine
    Director of Psychosocial Training
    Montefiore Medical Center
    New York, New York
    Michael L. Krychman, MD
    Executive Director
    Southern California Center for Sexual Health and Survivorship Medicine
    AASECT-certified Sexual Counselor

    Newport Beach, California
    Sexual Health and Menopause: Strategies for Improving Quality of Life
    Adele Case Study

    Release date: May 4, 2012

    Expiration date: May 4, 2013
    Estimated time to complete activity: 0.50 hours

    STATEMENT OF NEED
    Sexual health after menopause often falls by the wayside. Women are reluctant to discuss sexual issues with their health care providers and clinicians frequently do not inquire about their patients' sexual health. Despite safe and effective treatment options, only a minority of women will seek medical help for vulvovaginal atrophy and related sexual problems. This educational activity will help health care providers to proactively discuss sexual health and concerns with female patients, identify issues and improve both sexual health and patient care.

    TARGET AUDIENCE
    This activity has been designed to meet the educational needs of primary care providers, family practice providers, gynecologists, and other healthcare providers involved in the care of female patients.

    JOINT SPONSORSHIP
    This activity is jointly sponsored by Dannemiller, Inc. and Athena Education Group, LLC. 

    COMMERCIAL SUPPORT
    Commercial support for this activity has been provided through an educational grant from Pfizer, Inc.

    ACCREDITATION STATEMENT
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Dannemiller Inc. and Athena Education Group, LLC. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.

    CREDIT DESIGNATION
    Dannemiller designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Healthcare providers should only claim credit commensurate with the extent of their participation in the activity.

    METHOD OF PARTICIPATION
    There are no fees for participating in this CE activity. To participate in the activity and obtain credit:
    • Complete the post-test and activity evaluation.
    • Physicians, Nurse Practitioners, and Nurses who successfully complete the posttest and evaluation will receive credit.
    • All other participants who successfully complete the posttest and evaluation will receive a certificate of participation.
    • To obtain a certificate, participants must receive a score of 67% or better on the posttest.
    The posttest can be accessed at the end of the activity. A credit certificate will be available to print or save from your user history page. 

    CONTACT
    For questions regarding the content of this activity and technical assistance, please contact Dannemiller, the accredited provider for this CE activity, at editor@dannemiller.com.

    DISCLOSURE POLICY STATEMENT
    In accordance with the ACCME Standards for Commercial Support, Dannemiller requires that any person who is in a position to control the content of a CE activity must disclose all relevant financial relationships they have with a commercial interest.

    Faculty
    Sharon Parish, MD, discloses that she received compensation as a speaker and consultant for Boehringer-Ingelheim.
    Michael Krychman, MD, discloses that he received compensation as a speaker and consultant for Boehringer-Ingelheim, Johnson & Johnson, Pfizer, Warner Chilcott, and Wyeth.

    Athena Education Group
    Wendy Gloffke, PhD, medical writer, has no real or apparent conflicts of interest to report.
    Nike D. Gazonas, MS, has no real or apparent conflicts of interest to report.

    Dannemiller
    To resolve identified conflicts of interest, the educational content was fully peer-reviewed by a physician member of the Dannemiller Content Review Committee, who has no real or apparent conflicts of interest to report. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

    COURSE FORMAT
    Online case study activity.

    COURSE VIEWING REQUIREMENTS
    To view the activity online you will need the following hardware/software: Personal computer or smartphone with internet access, a Web browser (Google Chrome, Internet Explorer (v7.0+), Firefox (v3.5+), Safari (v4.0+) or Mozilla (v1.4+)) with JavaScript enabled.

    UNAPPROVED OR INVESTIGATIONAL USE STATEMENT

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration (FDA). Dannemiller, Athena Education Group, and the faculty do not recommend the use of any agent outside the labeled indications.

    Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, learners should critically evaluate the information presented and are encouraged to consult appropriate resources for any product or device mentioned in this activity.

    DISCLAIMER
    The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider regarding diagnosis and treatment of a specific patient's medical condition. This material is prepared based upon a review of multiple sources of information, but is not exhaustive of the subject matter. Therefore, healthcare providers should review and consider other publications and materials on the subject matter and not rely solely upon the information contained within this educational activity.

    PRIVACY AND CONFIDENTIALITY
    According to the American Medical Association (AMA), the Accreditation Council for Continuing Medical Education (ACCME), and other accrediting organizations, if a learner completes a CME/CE activity, Dannemiller is required to collect personal information on the individual, such as their name, address, and telephone number, that will allow Dannemiller to issue a CME/CE certificate to them and also Dannemiller must keep this information on file for up to 6 years.

    Personal information provided will be used only to meet AMA, ACCME, and/or other accreditation requirements and/or to issue CME/CE certificates to those who complete the educational activity. Information gathered on individuals who complete a CME/CE activity is stored in a secure database and is restricted to appropriate Dannemiller personnel. We use these databases to verify individual participation in a CME/CE activity and to re-issue a certificate to an individual if the certificate is lost or misplaced.

    Personal information gathered will not be released to any other company or organization for any purpose. This information remains totally confidential. At the end of the mandatory 6-year period, the records will be permanently destroyed.